Início › Sobrepeso › Louisiana

Ensaios clínicos de Sobrepeso em Louisiana

23 estudos para Sobrepeso estão buscando participantes em locais em Louisiana.

Cidades em Louisiana

Texto oficial do estudo (Inglês)

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Pennington Biomed Res Ctr, Baton Rouge

RecrutandoFase 3

Idades de 8 a 18 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07253285

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

BRCR Global Louisiana, Gretna

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07837973

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Southern Clin Research, Zachary

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Pennington Biomedical Research Center, Baton Rouge
IMA Clinical Research Monroe-Main, Monroe

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Care Access - New Iberia, New Iberia
Louisiana Research Center, Shreveport

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Velocity Clinical Research, Lafayette

RecrutandoFase 3

Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Care Access - New Iberia, New Iberia
Louisiana Research Center, Shreveport

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Clinical Trials Management, LLC d/b/a Flourish Research, Metairie
IMA Clinical Research Monroe - Armand, Monroe

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

IMA Clinical Research Monroe - Armand, Monroe

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Monroe

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Care Access - Shreveport 2, Shreveport

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Cardiovascular Associates Research, LLC, Covington
Tandem Clinical Research - Marrero, Marrero

RecrutandoFase 3

Idades de 45 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Care Access - Lake Charles (Bayou Pines), Lake Charles

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07321886

Impact of Lean Pork on Endothelial Function in Perimenopause

Pennington Biomedical Research Center, Baton Rouge

RecrutandoVoluntários saudáveis bem-vindos

Idades de 40 a 55 · Mulheres · Atualizado em 22 de set. de 2026 · NCT06976112

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Baton Rouge

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Baton Rouge
AURORA-2 Clinical Site, Metairie

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Elevate Clinical Research, Lake Charles
Nola Care Clinical Research Center, Metairie
DelRicht Clinical Research, LLC, New Orleans

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ascension DePaul Health, New Orleans

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351045

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Shreveport

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Velocity Clinical Research - Baton Rouge, Baton Rouge
Tandem Clinical Research - Marrero, Marrero

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684235

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Pennington Biomedical Research Center, Baton Rouge

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Baton Rouge

RecrutandoFase 3

Idades de 18 a 79 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07654361

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

Pennington Biomedical Research Center, Baton Rouge

RecrutandoVoluntários saudáveis bem-vindos

Idades de 18 a 42 · Todos os sexos · Atualizado em 8 de abr. de 2026 · NCT04583514

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.